title: New reports examine psychiatric risks of varenicline for smoking cessation.
authors.forename: Bridget M
authors.initials: BM
authors.lastname: Kuehn
mesh_terms: D001552:Benzazepines / Q000009:adverse effects*; D004348:Drug Labeling; D006760:Hospitalization / Q000706:statistics & numerical data; D006801:Humans; D018722:Nicotinic Agonists / Q000009:adverse effects*; D011810:Quinoxalines / Q000009:adverse effects*; D015203:Reproducibility of Results; D012306:Risk; D016540:Smoking Cessation / Q000379:methods*; D059020:Suicidal Ideation; D013405:Suicide / Q000706:statistics & numerical data*; D013406:Suicide, Attempted / Q000706:statistics & numerical data*; D014481:United States / Q000453:epidemiology; D014486:United States Food and Drug Administration; D000068580:Varenicline
chemical_list: D001552:Benzazepines; D018722:Nicotinic Agonists; D011810:Quinoxalines; D000068580:Varenicline